Jazz Pharmaceuticals plc insider trading
This tab shows only the shares insiders bought or sold on the open market in the last twelve months (Form 4 codes P and S). Grants, option exercises, shares held back for tax and gifts are left out on purpose, so what is left is insiders trading at the market price like anyone else.
In the last twelve months insiders at Jazz Pharmaceuticals plc filed 59 open-market sales worth $69.8 million and 0 open-market purchases, on Form 4 with the SEC. The latest: Gala Renee D, President & CEO, sold 2,000 shares at $236.40 on 6 October 2026, filed 7 October 2026.
| Traded | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 6 October 2026 | Gala Renee D | President & CEO | Sale | 2,000 | $236.40 | $472,800 | Form 4 |
| 1 October 2026 | Cozadd Bruce C | Director | Sale | 6,000 | $230.33 | $1.4 million | Form 4 |
| 10 September 2026 | Patil Neena M | EVP & Chief Legal Officer | Sale | 1,200 | $240.94 | $289,128 | Form 4 |
| 8 September 2026 | Gala Renee D | President & CEO | Sale | 2,000 | $243.03 | $486,060 | Form 4 |
| 1 September 2026 | Cozadd Bruce C | Director | Sale | 6,000 | $250.13 | $1.5 million | Form 4 |
| 27 August 2026 | Iannone Robert | EVP, Global Head of R&D & CMO | Sale | 18,187 | $247.86 | $4.5 million | Form 4 |
| 27 August 2026 | Iannone Robert | EVP, Global Head of R&D & CMO | Sale | 11,423 | $248.67 | $2.8 million | Form 4 |
| 27 August 2026 | Iannone Robert | EVP, Global Head of R&D & CMO | Sale | 18,113 | $250.02 | $4.5 million | Form 4 |
| 27 August 2026 | Iannone Robert | EVP, Global Head of R&D & CMO | Sale | 19,639 | $250.60 | $4.9 million | Form 4 |
| 27 August 2026 | Iannone Robert | EVP, Global Head of R&D & CMO | Sale | 9,259 | $251.95 | $2.3 million | Form 4 |
| 27 August 2026 | Iannone Robert | EVP, Global Head of R&D & CMO | Sale | 300 | $252.76 | $75,828 | Form 4 |
| 3 August 2026 | Cozadd Bruce C | Director | Sale | 6,000 | $252.98 | $1.5 million | Form 4 |
| 1 July 2026 | Cozadd Bruce C | Director | Sale | 6,000 | $240.47 | $1.4 million | Form 4 |
| 15 June 2026 | Smith Mark Douglas | Director | Sale | 1,157 | $230.55 | $266,746 | Form 4 |
| 10 June 2026 | Patil Neena M | EVP & Chief Legal Officer | Sale | 1,200 | $231.83 | $278,196 | Form 4 |
| 1 June 2026 | Cozadd Bruce C | Director | Sale | 6,000 | $235.12 | $1.4 million | Form 4 |
| 28 May 2026 | Patil Neena M | EVP & Chief Legal Officer | Sale | 1,192 | $236.97 | $282,468 | Form 4 |
| 28 May 2026 | Pearce Samantha | EVP, Chief Commercial Officer | Sale | 6,907 | $235.41 | $1.6 million | Form 4 |
| 22 May 2026 | Winningham Rick E | Director | Sale | 2,741 | $241.57 | $662,143 | Form 4 |
| 22 May 2026 | Mcsharry Heather Ann | Director | Sale | 2,000 | $241.00 | $482,000 | Form 4 |
| 1 May 2026 | Cozadd Bruce C | Director | Sale | 6,000 | $203.33 | $1.2 million | Form 4 |
| 1 April 2026 | Cozadd Bruce C | Director | Sale | 3,684 | $190.22 | $700,778 | Form 4 |
| 1 April 2026 | Cozadd Bruce C | Director | Sale | 2,292 | $190.94 | $437,631 | Form 4 |
| 1 April 2026 | Cozadd Bruce C | Director | Sale | 24 | $191.74 | $4,602 | Form 4 |
| 9 March 2026 | Carr Patricia | SVP, Chief Accounting Officer | Sale | 1,287 | $182.94 | $235,444 | Form 4 |
| 3 March 2026 | Cozadd Bruce C | Director | Sale | 3,159 | $186.09 | $587,843 | Form 4 |
| 3 March 2026 | Cozadd Bruce C | Director | Sale | 2,608 | $186.73 | $487,002 | Form 4 |
| 3 March 2026 | Cozadd Bruce C | Director | Sale | 233 | $187.84 | $43,768 | Form 4 |
| 27 February 2026 | Riedel Norbert G | Director | Sale | 3,415 | $192.00 | $655,680 | Form 4 |
| 27 February 2026 | Carr Patricia | SVP, Chief Accounting Officer | Sale | 1,117 | $190.91 | $213,243 | Form 4 |
| 26 February 2026 | Carr Patricia | SVP, Chief Accounting Officer | Sale | 1,253 | $194.11 | $243,222 | Form 4 |
| 26 February 2026 | Patil Neena M | EVP & Chief Legal Officer | Sale | 16,602 | $192.53 | $3.2 million | Form 4 |
| 26 February 2026 | Patil Neena M | EVP & Chief Legal Officer | Sale | 875 | $192.07 | $168,057 | Form 4 |
| 26 February 2026 | Patil Neena M | EVP & Chief Legal Officer | Sale | 15,555 | $190.28 | $3.0 million | Form 4 |
| 26 February 2026 | Patil Neena M | EVP & Chief Legal Officer | Sale | 2,916 | $189.81 | $553,491 | Form 4 |
| 26 February 2026 | Patil Neena M | EVP & Chief Legal Officer | Sale | 11,529 | $191.65 | $2.2 million | Form 4 |
| 26 February 2026 | Patil Neena M | EVP & Chief Legal Officer | Sale | 3,523 | $193.58 | $681,993 | Form 4 |
| 26 February 2026 | Patil Neena M | EVP & Chief Legal Officer | Sale | 1,061 | $190.00 | $201,594 | Form 4 |
| 26 February 2026 | Patil Neena M | EVP & Chief Legal Officer | Sale | 549 | $190.80 | $104,747 | Form 4 |
| 26 February 2026 | Patil Neena M | EVP & Chief Legal Officer | Sale | 1,784 | $191.88 | $342,312 | Form 4 |
| 26 February 2026 | Patil Neena M | EVP & Chief Legal Officer | Sale | 1,009 | $192.79 | $194,527 | Form 4 |
| 26 February 2026 | Patil Neena M | EVP & Chief Legal Officer | Sale | 197 | $193.60 | $38,139 | Form 4 |
| 26 February 2026 | Henderson Mary Elizabeth | SVP, Technical Operations | Sale | 5,343 | $194.49 | $1.0 million | Form 4 |
| 9 December 2025 | Henderson Mary Elizabeth | SVP, Technical Operations | Sale | 2,238 | $169.51 | $379,366 | Form 4 |
| 5 December 2025 | Carr Patricia | SVP, Chief Accounting Officer | Sale | 160 | $171.11 | $27,378 | Form 4 |
| 5 December 2025 | Carr Patricia | SVP, Chief Accounting Officer | Sale | 4,500 | $171.20 | $770,405 | Form 4 |
| 26 November 2025 | Cozadd Bruce C | Director | Sale | 30,487 | $178.06 | $5.4 million | Form 4 |
| 26 November 2025 | Cozadd Bruce C | Director | Sale | 8,380 | $179.23 | $1.5 million | Form 4 |
| 26 November 2025 | Cozadd Bruce C | Director | Sale | 507 | $179.79 | $91,155 | Form 4 |
| 26 November 2025 | Cozadd Bruce C | Director | Sale | 38,126 | $177.27 | $6.8 million | Form 4 |
| 20 November 2025 | Mcsharry Heather Ann | Director | Sale | 3,415 | $177.78 | $607,127 | Form 4 |
| 18 November 2025 | Cozadd Bruce C | Director | Sale | 3,384 | $180.09 | $609,411 | Form 4 |
| 18 November 2025 | Cozadd Bruce C | Director | Sale | 8,382 | $180.88 | $1.5 million | Form 4 |
| 18 November 2025 | Cozadd Bruce C | Director | Sale | 5,517 | $181.81 | $1.0 million | Form 4 |
| 18 November 2025 | Cozadd Bruce C | Director | Sale | 717 | $182.60 | $130,925 | Form 4 |
| 18 November 2025 | Carr Patricia | SVP, Chief Accounting Officer | Sale | 69 | $181.66 | $12,535 | Form 4 |
| 18 November 2025 | Carr Patricia | SVP, Chief Accounting Officer | Sale | 5,250 | $182.07 | $955,868 | Form 4 |
| 18 November 2025 | Winningham Rick E | Director | Sale | 5,500 | $180.86 | $994,728 | Form 4 |
| 17 November 2025 | Iannone Robert | EVP, Global Head of R&D & CMO | Sale | 7,159 | $168.26 | $1.2 million | Form 4 |
A filing with several lines appears once per line.
Source
Form 4 filings on EDGAR for Jazz Pharmaceuticals plc: the company's filing index.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.